Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Citations over U.S. vaccine mandate could begin in early January

Published 12/18/2021, 03:54 PM
Updated 12/18/2021, 04:40 PM
© Reuters. A person walks past a vaccination site as the Omicron coronavirus variant continues to spread in Brooklyn, New York City, U.S., December 18, 2021. REUTERS/Andrew Kelly

By Jason Lange

WASHINGTON (Reuters) - A U.S. federal agency on Saturday said it could start issuing citations to companies as soon as Jan. 10 for failure to comply with a nationwide mandate that they either vaccinate or test regularly for COVID-19, as a U.S. Supreme Court showdown over the policy looms.

The announcement came one day after a U.S. appeals court reinstated the Biden administration policy that requires large businesses to verify employees are vaccinated against COVID-19 or submit to weekly testing.

Another court in November had blocked the rule from the Occupational Safety and Health Administration (OSHA), and the legal battle is expected to continue to the Supreme Court.

On Saturday, OSHA said it would not cite companies for any kind of noncompliance with the rule before Jan. 10 "to provide employers with sufficient time to come into compliance." OSHA also said citations around COVID-19 testing would not begin before Feb. 9.

The OSHA rule applies to businesses with at least 100 workers and covers 80 million American workers.

The rule has triggered a significant backlash, particularly in Republican-leaning states. Republicans hope to make popular frustration with COVID-19 safety measures a central theme in political campaigns ahead of the November 2022 congressional elections, when Republican hope to seize control of Congress.

President Joe Biden has argued the vaccine mandate is essential for fighting the pandemic, which has killed more than 750,000 Americans and weighed on the economy.

© Reuters. A nurse prepares to administer a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19), at a mobile inoculation site in the Bronx borough of New York City, New York, U.S., August 18, 2021.  REUTERS/David 'Dee' Delgado

Biden will announce new steps for fighting the pandemic on Tuesday, a White House spokesperson said.

The debate coincides with public health officials bracing for a "tidal wave" https://www.reuters.com/world/us/tidal-wave-omicron-could-put-us-covid-19-surge-into-overdrive-2021-12-17 of coronavirus infections in the United States as the more transmissible Omicron variant spreads rapidly worldwide.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.